by: Parent Project Muscular DystrophyNS Pharma joined PPMD on March 13, 2024 for a community webinar providing an overview of two new exon skipping trials: Brogidirsen (exon 44) and NS-050/NCNP-03 (exon 50). Vamshi Rao, MD, discussed these two new clinical trials for individuals with Duchenne who are amenable to either exon 44 or exon 50 skipping. Both trials are sponsored by NS Pharma.
